HEADER GLYCOGEN METABOLISM 25-MAY-01 1H5U TITLE THE 1.76 A RESOLUTION CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B TITLE 2 COMPLEXED WITH GLUCOSE AND CP320626, A POTENTIAL ANTIDIABETIC DRUG COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYCOGEN PHOSPHORYLASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MYOPHOSPHORYLASE; COMPND 5 EC: 2.4.1.1 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ORYCTOLAGUS CUNICULUS; SOURCE 3 ORGANISM_COMMON: RABBIT; SOURCE 4 ORGANISM_TAXID: 9986; SOURCE 5 TISSUE: MUSCLE KEYWDS GLYCOGEN METABOLISM, GLYCOGEN PHOSPHORYLASE B, INHIBITION, CENTRAL KEYWDS 2 CAVITY, DRUG BINDING SITE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR N.G.OIKONOMAKOS,S.E.ZOGRAPHOS,V.T.SKAMNAKI,G.ARCHONTIS REVDAT 7 13-DEC-23 1H5U 1 HETSYN REVDAT 6 29-JUL-20 1H5U 1 COMPND REMARK HETNAM SITE REVDAT 5 24-JUL-19 1H5U 1 REMARK REVDAT 4 22-MAY-19 1H5U 1 REMARK LINK REVDAT 3 24-FEB-09 1H5U 1 VERSN REVDAT 2 15-MAR-02 1H5U 1 JRNL REVDAT 1 28-JUN-01 1H5U 0 JRNL AUTH N.G.OIKONOMAKOS,S.E.ZOGRAPHOS,V.T.SKAMNAKI,G.ARCHONTIS JRNL TITL THE 1.76 A RESOLUTION CRYSTAL STRUCTURE OF GLYCOGEN JRNL TITL 2 PHOSPHORYLASE B COMPLEXED WITH GLUCOSE, AND CP320626, A JRNL TITL 3 POTENTIAL ANTIDIABETIC DRUG JRNL REF BIOORG.MED.CHEM. V. 10 1313 2002 JRNL REFN ISSN 0968-0896 JRNL PMID 11886794 JRNL DOI 10.1016/S0968-0896(01)00394-7 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH N.G.OIKONOMAKOS,V.T.SKAMNAKI,K.E.TSITSANOU,N.G.GAVALAS, REMARK 1 AUTH 2 L.N.JOHNSON REMARK 1 TITL A NEW ALLOSTERIC SITE IN GLYCOGEN PHOSPHORYLASE B AS A REMARK 1 TITL 2 TARGET FOR DRUG INTERACTIONS REMARK 1 REF STRUCTURE V. 8 575 2000 REMARK 1 REFN ISSN 0969-2126 REMARK 1 PMID 10873856 REMARK 1 DOI 10.1016/S0969-2126(00)00144-1 REMARK 2 REMARK 2 RESOLUTION. 1.76 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.8 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.76 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.25 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.8 REMARK 3 NUMBER OF REFLECTIONS : 92971 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.235 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4663 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6591 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 355 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.250 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.680 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.500 ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.000 ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : 1.500 ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.000 ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RESIDUES WHERE B-FACTOR VALUES OF MAIN REMARK 3 CHAIN ATOMS EXCEED 60 A2 INCLUDE 13-17, 209-211, 250-254, 260, REMARK 3 313-314, 324-325, 550-557, AND 831-837. THE SAME RESIDUES ARE REMARK 3 ALSO POORLY ORDERED IN THE NATIVE ENZYME STRUCTURE REMARK 4 REMARK 4 1H5U COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 25-MAY-01. REMARK 100 THE DEPOSITION ID IS D_1290008121. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-MAR-00 REMARK 200 TEMPERATURE (KELVIN) : 287.0 REMARK 200 PH : 6.70 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : X31 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.05 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 180 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 93061 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.760 REMARK 200 RESOLUTION RANGE LOW (A) : 26.250 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.05400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.4100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.76 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.79 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.69600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.330 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: 1C50 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.48 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PHOSPHORYLASE B-GLC-CP320626 COMPLEX REMARK 280 WAS CO-CRYSTALLISED UNDER CONDITIONS SIMILAR TO THOSE DESCRIBED REMARK 280 BY OIKONOMAKOS ET AL., (2000) STRUCTURE 8, 575-584., PH 6.70 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 58.09300 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 64.48300 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 64.48300 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 87.13950 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 64.48300 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 64.48300 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 29.04650 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 64.48300 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 64.48300 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 87.13950 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 64.48300 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 64.48300 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 29.04650 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 58.09300 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 116.18600 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1 REMARK 465 ARG A 2 REMARK 465 PRO A 3 REMARK 465 LEU A 4 REMARK 465 SER A 5 REMARK 465 ASP A 6 REMARK 465 GLN A 7 REMARK 465 GLU A 8 REMARK 465 LYS A 9 REMARK 465 ARG A 10 REMARK 465 LYS A 11 REMARK 465 GLN A 12 REMARK 465 LYS A 255 REMARK 465 ASP A 256 REMARK 465 PHE A 257 REMARK 465 ASN A 258 REMARK 465 VAL A 259 REMARK 465 LYS A 315 REMARK 465 PHE A 316 REMARK 465 GLY A 317 REMARK 465 CYS A 318 REMARK 465 ARG A 319 REMARK 465 ASP A 320 REMARK 465 PRO A 321 REMARK 465 VAL A 322 REMARK 465 ARG A 323 REMARK 465 ASP A 838 REMARK 465 GLU A 839 REMARK 465 LYS A 840 REMARK 465 ILE A 841 REMARK 465 PRO A 842 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O PHE A 252 N LEU A 254 1.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 14 165.62 148.96 REMARK 500 ALA A 19 72.13 -115.23 REMARK 500 ARG A 43 -14.67 -49.89 REMARK 500 LEU A 131 46.25 -86.00 REMARK 500 TYR A 203 -132.59 60.92 REMARK 500 SER A 210 -72.97 11.25 REMARK 500 GLN A 211 65.06 -100.78 REMARK 500 ASP A 251 -100.00 -84.79 REMARK 500 ASN A 253 40.00 -58.46 REMARK 500 PRO A 281 29.82 -78.29 REMARK 500 ASP A 339 -167.86 74.39 REMARK 500 THR A 466 -88.65 -126.55 REMARK 500 LEU A 492 -70.67 -145.93 REMARK 500 ASP A 514 67.14 -158.77 REMARK 500 LYS A 554 98.98 43.73 REMARK 500 VAL A 555 -46.66 -153.25 REMARK 500 HIS A 556 129.74 77.82 REMARK 500 LYS A 568 172.32 174.87 REMARK 500 SER A 674 -62.52 -148.20 REMARK 500 SER A 751 73.92 -152.22 REMARK 500 ASN A 793 79.28 -118.72 REMARK 500 PRO A 835 71.67 -45.32 REMARK 500 ALA A 836 174.00 43.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A8I RELATED DB: PDB REMARK 900 SPIROHYDANTOIN INHIBITOR OF GLYCOGEN PHOSPHORYLASE REMARK 900 RELATED ID: 1ABB RELATED DB: PDB REMARK 900 GLYCOGEN PHOSPHORYLASE COMPLEX WITH PYRIDOXAL- 5'-DIPHOSPHATE REMARK 900 RELATED ID: 1AXR RELATED DB: PDB REMARK 900 COOPERATIVITY BETWEEN HYDROGEN-BONDING AND CHARGE-DIPOLE REMARK 900 INTERACTIONS IN THE INHIBITION OF BETA-GLYCOSIDASES BY REMARK 900 AZOLOPYRIDINES: EVIDENCE FROM A STUDY WITH GLYCOGEN PHOSPHORYLASE B REMARK 900 RELATED ID: 1B4D RELATED DB: PDB REMARK 900 AMIDOCARBAMATE INHIBITOR OF GLYCOGEN PHOSPHORYLASE REMARK 900 RELATED ID: 1BX3 RELATED DB: PDB REMARK 900 EFFECTS OF COMMONLY USED CRYOPROTECTANTS ON GLYCOGEN PHOSPHORYLASE REMARK 900 ACTIVITY AND STRUCTURE REMARK 900 RELATED ID: 1C50 RELATED DB: PDB REMARK 900 IDENTIFICATION AND STRUCTURAL CHARACTERIZATION OF A NOVEL REMARK 900 ALLOSTERIC BINDING SITE OF GLYCOGEN PHOSPHORYLASE B REMARK 900 RELATED ID: 1C8K RELATED DB: PDB REMARK 900 FLAVOPIRIDOL INHIBITS GLYCOGEN PHOSPHORYLASE BY BINDING AT THE REMARK 900 INHIBITOR SITE REMARK 900 RELATED ID: 1C8L RELATED DB: PDB REMARK 900 SYNERGISTIC INHIBITION OF GLYCOGEN PHOSPHORYLASE A BY A POTENTIAL REMARK 900 ANTIDIABETIC DRUG AND CAFFEINE REMARK 900 RELATED ID: 1E1Y RELATED DB: PDB REMARK 900 LAVOPIRIDOL INHIBITS GLYCOGEN PHOSPHORYLASE BY BINDING AT THE REMARK 900 INHIBITOR SITE REMARK 900 RELATED ID: 1FS4 RELATED DB: PDB REMARK 900 STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXESAND THE REMARK 900 IMPLICATIONS FOR STRUCTURE- BASED DRUG DESIGN REMARK 900 RELATED ID: 1FTQ RELATED DB: PDB REMARK 900 STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXESAND THE REMARK 900 IMPLICATIONS FOR STRUCTURE- BASED DRUG DESIGN REMARK 900 RELATED ID: 1FTW RELATED DB: PDB REMARK 900 STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXESAND THE REMARK 900 IMPLICATIONS FOR STRUCTURE- BASED DRUG DESIGN REMARK 900 RELATED ID: 1FTY RELATED DB: PDB REMARK 900 STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXESAND THE REMARK 900 IMPLICATIONS FOR STRUCTURE- BASED DRUG DESIGN REMARK 900 RELATED ID: 1FU4 RELATED DB: PDB REMARK 900 STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXESAND THE REMARK 900 IMPLICATIONS FOR STRUCTURE- BASED DRUG DESIGN REMARK 900 RELATED ID: 1FU7 RELATED DB: PDB REMARK 900 STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXESAND THE REMARK 900 IMPLICATIONS FOR STRUCTURE- BASED DRUG DESIGN REMARK 900 RELATED ID: 1FU8 RELATED DB: PDB REMARK 900 STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXESAND THE REMARK 900 IMPLICATIONS FOR STRUCTURE- BASED DRUG DESIGN REMARK 900 RELATED ID: 1GFZ RELATED DB: PDB REMARK 900 FLAVOPIRIDOL INHIBITS GLYCOGEN PHOSPHORYLASE BY BINDING ATTHE REMARK 900 INHIBITOR SITE REMARK 900 RELATED ID: 1GG8 RELATED DB: PDB REMARK 900 DESIGN OF INHIBITORS OF GLYCOGEN PHOSPHORYLASE : A STUDY OFALPHA- REMARK 900 AND BETA-C-GLUCOSIDES AND 1-THIO-BETA-D-GLUCOSECOMPOUNDS REMARK 900 RELATED ID: 1GGN RELATED DB: PDB REMARK 900 STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXESAND THE REMARK 900 IMPLICATIONS FOR STRUCTURE- BASED DRUG DESIGN REMARK 900 RELATED ID: 1GPA RELATED DB: PDB REMARK 900 GLYCOGEN PHOSPHORYLASE A (R STATE) REMARK 900 RELATED ID: 1GPB RELATED DB: PDB REMARK 900 GLYCOGEN PHOSPHORYLASE B (T STATE) REMARK 900 RELATED ID: 1GPY RELATED DB: PDB REMARK 900 GLYCOGEN PHOSPHORYLASE B (T STATE) COMPLEX WITH ALPHA-D-GLUCOSE-6- REMARK 900 PHOSPHATE REMARK 900 RELATED ID: 1HLF RELATED DB: PDB REMARK 900 BINDING OF GLUCOPYRANOSYLIDENE-SPIRO- THIOHYDANTOIN TOGLYCOGEN REMARK 900 PHOSPHORYLASE B: KINETIC AND CRYSTALLOGRAPHIC STUD REMARK 900 RELATED ID: 1NOI RELATED DB: PDB REMARK 900 COMPLEX OF GLYCOGEN PHOSPHORYLASE WITH A TRANSITION STATE ANALOGUE REMARK 900 NOJIRIMYCIN TETRAZOLE AND PHOSPHATE IN THE T AND R STATES REMARK 900 RELATED ID: 1NOJ RELATED DB: PDB REMARK 900 COMPLEX OF GLYCOGEN PHOSPHORYLASE WITH A TRANSITION STATE ANALOGUE REMARK 900 NOJIRIMYCIN TETRAZOLE AND PHOSPHATE IN THE T STATE REMARK 900 RELATED ID: 1NOK RELATED DB: PDB REMARK 900 COMPLEX OF GLYCOGEN PHOSPHORYLASE WITH A TRANSITION STATE ANALOGUE REMARK 900 NOJIRIMYCIN TETRAZOLE AND PHOSPHATE IN THE T STATE REMARK 900 RELATED ID: 1PYG RELATED DB: PDB REMARK 900 GLYCOGEN PHOSPHORYLASE B (PYRIDOXAL-5'- PYROPHOSPHORYL DERIVATIVE) REMARK 900 COMPLEX WITH ADENOSINE MONOPHOSPHATE REMARK 900 RELATED ID: 2AMV RELATED DB: PDB REMARK 900 THE STRUCTURE OF GLYCOGEN PHOSPHORYLASE B WITH AN ALKYL- REMARK 900 DIHYDROPYRIDINE-DICARBOXYLIC ACID REMARK 900 RELATED ID: 2GPA RELATED DB: PDB REMARK 900 ALLOSTERIC INHIBITION OF GLYCOGEN PHOSPHORYLASE A BY A POTENTIAL REMARK 900 ANTIDIABETIC DRUG REMARK 900 RELATED ID: 2GPB RELATED DB: PDB REMARK 900 GLYCOGEN PHOSPHORYLASE B (T STATE) COMPLEX WITH ALPHA-D-GLUCOSE REMARK 900 RELATED ID: 2GPN RELATED DB: PDB REMARK 900 100 K STRUCTURE OF GLYCOGEN PHOSPHORYLASE AT 2.0 ANGSTROMS REMARK 900 RESOLUTION REMARK 900 RELATED ID: 2PRI RELATED DB: PDB REMARK 900 BINDING OF 2-DEOXY-GLUCOSE-6-PHOSPHATE TO GLYCOGEN PHOSPHORYLASE B REMARK 900 RELATED ID: 2PRJ RELATED DB: PDB REMARK 900 BINDING OF 2-DEOXY-GLUCOSE-6-PHOSPHATE TO GLYCOGEN PHOSPHORYLASE B REMARK 900 RELATED ID: 2SKC RELATED DB: PDB REMARK 900 PYRIDOXAL PHOSPHORYLASE B IN COMPLEX WITH FLUOROPHOSPHATE, GLUCOSE REMARK 900 AND INOSINE-5'- MONOPHOSPHATE REMARK 900 RELATED ID: 2SKD RELATED DB: PDB REMARK 900 PYRIDOXAL PHOSPHORYLASE B IN COMPLEX WITH PHOSPHATE, GLUCOSE AND REMARK 900 INOSINE-5'- MONOPHOSPHATE REMARK 900 RELATED ID: 2SKE RELATED DB: PDB REMARK 900 PYRIDOXAL PHOSPHORYLASE B IN COMPLEX WITH PHOSPHITE, GLUCOSE AND REMARK 900 INOSINE-5'- MONOPHOSPHATE REMARK 900 RELATED ID: 3AMV RELATED DB: PDB REMARK 900 ALLOSTERIC INHIBITION OF GLYCOGEN PHOSPHORYLASE A BY A POTENTIAL REMARK 900 ANTIDIABETIC DRUG REMARK 900 RELATED ID: 3GPB RELATED DB: PDB REMARK 900 GLYCOGEN PHOSPHORYLASE B (T STATE) COMPLEX WITH ALPHA-D-GLUCOSE-1- REMARK 900 PHOSPHATE REMARK 900 RELATED ID: 4GPB RELATED DB: PDB REMARK 900 GLYCOGEN PHOSPHORYLASE B (T STATE) COMPLEX WITH 2-FLUORO-2-DEOXY- REMARK 900 ALPHA-D-GLUCOSE-1 -PHOSPHATE REMARK 900 RELATED ID: 5GPB RELATED DB: PDB REMARK 900 GLYCOGEN PHOSPHORYLASE B (T STATE) COMPLEX WITH ALPHA-D-GLUCOSE-1- REMARK 900 METHYLENE-PHOSPHATE AND MALTOHEXAOSE REMARK 900 RELATED ID: 6GPB RELATED DB: PDB REMARK 900 GLYCOGEN PHOSPHORYLASE B (T STATE) COMPLEX WITH HEPTULOSE 2- REMARK 900 PHOSPHATE AND MALTOHEPTAOSE AND AMP REMARK 900 RELATED ID: 7GPB RELATED DB: PDB REMARK 900 GLYCOGEN PHOSPHORYLASE B (R STATE) COMPLEX WITH AMP REMARK 900 RELATED ID: 8GPB RELATED DB: PDB REMARK 900 GLYCOGEN PHOSPHORYLASE B (T STATE) COMPLEX WITH AMP REMARK 900 RELATED ID: 9GPB RELATED DB: PDB REMARK 900 GLYCOGEN PHOSPHORYLASE B (R STATE) REMARK 999 REMARK 999 SEQUENCE REMARK 999 REFERENCE: K.NAKANO, P.K.HWANG, R.J.FLETTERICK, FEBS REMARK 999 LETT., V. 204, P. 283, 1986. REMARK 999 REMARK 999 HIGH RESOLUTION DATA (1.5 ANGSTROMS) REFINEMENT ON T-STATE REMARK 999 GLYCOGEN PHOSPHORYLASE (UNPUBLISHED RESULTS) HAS CONFIRMED REMARK 999 THAT RESIDUE 609 IS INDEED ALA (NOT PRO). DBREF 1H5U A 1 842 UNP P00489 PHS2_RABIT 1 842 SEQADV 1H5U ILE A 380 UNP P00489 LEU 380 CONFLICT SEQRES 1 A 842 SER ARG PRO LEU SER ASP GLN GLU LYS ARG LYS GLN ILE SEQRES 2 A 842 SER VAL ARG GLY LEU ALA GLY VAL GLU ASN VAL THR GLU SEQRES 3 A 842 LEU LYS LYS ASN PHE ASN ARG HIS LEU HIS PHE THR LEU SEQRES 4 A 842 VAL LYS ASP ARG ASN VAL ALA THR PRO ARG ASP TYR TYR SEQRES 5 A 842 PHE ALA LEU ALA HIS THR VAL ARG ASP HIS LEU VAL GLY SEQRES 6 A 842 ARG TRP ILE ARG THR GLN GLN HIS TYR TYR GLU LYS ASP SEQRES 7 A 842 PRO LYS ARG ILE TYR TYR LEU SER LEU GLU PHE TYR MET SEQRES 8 A 842 GLY ARG THR LEU GLN ASN THR MET VAL ASN LEU ALA LEU SEQRES 9 A 842 GLU ASN ALA CYS ASP GLU ALA THR TYR GLN LEU GLY LEU SEQRES 10 A 842 ASP MET GLU GLU LEU GLU GLU ILE GLU GLU ASP ALA GLY SEQRES 11 A 842 LEU GLY ASN GLY GLY LEU GLY ARG LEU ALA ALA CYS PHE SEQRES 12 A 842 LEU ASP SER MET ALA THR LEU GLY LEU ALA ALA TYR GLY SEQRES 13 A 842 TYR GLY ILE ARG TYR GLU PHE GLY ILE PHE ASN GLN LYS SEQRES 14 A 842 ILE CYS GLY GLY TRP GLN MET GLU GLU ALA ASP ASP TRP SEQRES 15 A 842 LEU ARG TYR GLY ASN PRO TRP GLU LYS ALA ARG PRO GLU SEQRES 16 A 842 PHE THR LEU PRO VAL HIS PHE TYR GLY ARG VAL GLU HIS SEQRES 17 A 842 THR SER GLN GLY ALA LYS TRP VAL ASP THR GLN VAL VAL SEQRES 18 A 842 LEU ALA MET PRO TYR ASP THR PRO VAL PRO GLY TYR ARG SEQRES 19 A 842 ASN ASN VAL VAL ASN THR MET ARG LEU TRP SER ALA LYS SEQRES 20 A 842 ALA PRO ASN ASP PHE ASN LEU LYS ASP PHE ASN VAL GLY SEQRES 21 A 842 GLY TYR ILE GLN ALA VAL LEU ASP ARG ASN LEU ALA GLU SEQRES 22 A 842 ASN ILE SER ARG VAL LEU TYR PRO ASN ASP ASN PHE PHE SEQRES 23 A 842 GLU GLY LYS GLU LEU ARG LEU LYS GLN GLU TYR PHE VAL SEQRES 24 A 842 VAL ALA ALA THR LEU GLN ASP ILE ILE ARG ARG PHE LYS SEQRES 25 A 842 SER SER LYS PHE GLY CYS ARG ASP PRO VAL ARG THR ASN SEQRES 26 A 842 PHE ASP ALA PHE PRO ASP LYS VAL ALA ILE GLN LEU ASN SEQRES 27 A 842 ASP THR HIS PRO SER LEU ALA ILE PRO GLU LEU MET ARG SEQRES 28 A 842 VAL LEU VAL ASP LEU GLU ARG LEU ASP TRP ASP LYS ALA SEQRES 29 A 842 TRP GLU VAL THR VAL LYS THR CYS ALA TYR THR ASN HIS SEQRES 30 A 842 THR VAL ILE PRO GLU ALA LEU GLU ARG TRP PRO VAL HIS SEQRES 31 A 842 LEU LEU GLU THR LEU LEU PRO ARG HIS LEU GLN ILE ILE SEQRES 32 A 842 TYR GLU ILE ASN GLN ARG PHE LEU ASN ARG VAL ALA ALA SEQRES 33 A 842 ALA PHE PRO GLY ASP VAL ASP ARG LEU ARG ARG MET SER SEQRES 34 A 842 LEU VAL GLU GLU GLY ALA VAL LYS ARG ILE ASN MET ALA SEQRES 35 A 842 HIS LEU CYS ILE ALA GLY SER HIS ALA VAL ASN GLY VAL SEQRES 36 A 842 ALA ARG ILE HIS SER GLU ILE LEU LYS LYS THR ILE PHE SEQRES 37 A 842 LYS ASP PHE TYR GLU LEU GLU PRO HIS LYS PHE GLN ASN SEQRES 38 A 842 LYS THR ASN GLY ILE THR PRO ARG ARG TRP LEU VAL LEU SEQRES 39 A 842 CYS ASN PRO GLY LEU ALA GLU ILE ILE ALA GLU ARG ILE SEQRES 40 A 842 GLY GLU GLU TYR ILE SER ASP LEU ASP GLN LEU ARG LYS SEQRES 41 A 842 LEU LEU SER TYR VAL ASP ASP GLU ALA PHE ILE ARG ASP SEQRES 42 A 842 VAL ALA LYS VAL LYS GLN GLU ASN LYS LEU LYS PHE ALA SEQRES 43 A 842 ALA TYR LEU GLU ARG GLU TYR LYS VAL HIS ILE ASN PRO SEQRES 44 A 842 ASN SER LEU PHE ASP VAL GLN VAL LYS ARG ILE HIS GLU SEQRES 45 A 842 TYR LYS ARG GLN LEU LEU ASN CYS LEU HIS VAL ILE THR SEQRES 46 A 842 LEU TYR ASN ARG ILE LYS LYS GLU PRO ASN LYS PHE VAL SEQRES 47 A 842 VAL PRO ARG THR VAL MET ILE GLY GLY LYS ALA ALA PRO SEQRES 48 A 842 GLY TYR HIS MET ALA LYS MET ILE ILE LYS LEU ILE THR SEQRES 49 A 842 ALA ILE GLY ASP VAL VAL ASN HIS ASP PRO VAL VAL GLY SEQRES 50 A 842 ASP ARG LEU ARG VAL ILE PHE LEU GLU ASN TYR ARG VAL SEQRES 51 A 842 SER LEU ALA GLU LYS VAL ILE PRO ALA ALA ASP LEU SER SEQRES 52 A 842 GLU GLN ILE SER THR ALA GLY THR GLU ALA SER GLY THR SEQRES 53 A 842 GLY ASN MET LYS PHE MET LEU ASN GLY ALA LEU THR ILE SEQRES 54 A 842 GLY THR MET ASP GLY ALA ASN VAL GLU MET ALA GLU GLU SEQRES 55 A 842 ALA GLY GLU GLU ASN PHE PHE ILE PHE GLY MET ARG VAL SEQRES 56 A 842 GLU ASP VAL ASP ARG LEU ASP GLN ARG GLY TYR ASN ALA SEQRES 57 A 842 GLN GLU TYR TYR ASP ARG ILE PRO GLU LEU ARG GLN ILE SEQRES 58 A 842 ILE GLU GLN LEU SER SER GLY PHE PHE SER PRO LYS GLN SEQRES 59 A 842 PRO ASP LEU PHE LYS ASP ILE VAL ASN MET LEU MET HIS SEQRES 60 A 842 HIS ASP ARG PHE LYS VAL PHE ALA ASP TYR GLU GLU TYR SEQRES 61 A 842 VAL LYS CYS GLN GLU ARG VAL SER ALA LEU TYR LYS ASN SEQRES 62 A 842 PRO ARG GLU TRP THR ARG MET VAL ILE ARG ASN ILE ALA SEQRES 63 A 842 THR SER GLY LYS PHE SER SER ASP ARG THR ILE ALA GLN SEQRES 64 A 842 TYR ALA ARG GLU ILE TRP GLY VAL GLU PRO SER ARG GLN SEQRES 65 A 842 ARG LEU PRO ALA PRO ASP GLU LYS ILE PRO HET CHI A 920 31 HET GLC A 998 12 HET PLP A 999 15 HETNAM CHI 5-CHLORO-1H-INDOLE-2-CARBOXYLIC ACID [1-(4- HETNAM 2 CHI FLUOROBENZYL)-2-(4-HYDROXYPIPERIDIN-1YL)-2- HETNAM 3 CHI OXOETHYL]AMIDE HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM PLP PYRIDOXAL-5'-PHOSPHATE HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE HETSYN PLP VITAMIN B6 PHOSPHATE FORMUL 2 CHI C23 H23 CL F N3 O3 FORMUL 3 GLC C6 H12 O6 FORMUL 4 PLP C8 H10 N O6 P FORMUL 5 HOH *355(H2 O) HELIX 1 1 GLY A 20 THR A 38 1 19 HELIX 2 2 THR A 47 ASP A 78 1 32 HELIX 3 3 THR A 94 LEU A 102 1 9 HELIX 4 4 LEU A 104 LEU A 115 1 12 HELIX 5 5 ASP A 118 GLU A 124 1 7 HELIX 6 6 GLY A 134 LEU A 150 1 17 HELIX 7 7 PRO A 194 THR A 197 5 4 HELIX 8 8 GLY A 261 ASP A 268 1 8 HELIX 9 9 ARG A 269 ARG A 277 5 9 HELIX 10 10 LYS A 289 SER A 314 1 26 HELIX 11 11 ASN A 325 ASP A 327 5 3 HELIX 12 12 ALA A 328 LYS A 332 1 5 HELIX 13 13 LEU A 344 LEU A 356 1 13 HELIX 14 14 ASP A 360 THR A 371 1 12 HELIX 15 15 ILE A 380 LEU A 384 5 5 HELIX 16 16 VAL A 389 LEU A 396 1 8 HELIX 17 17 LEU A 396 PHE A 418 1 23 HELIX 18 18 ASP A 421 SER A 429 1 9 HELIX 19 19 MET A 441 GLY A 448 1 8 HELIX 20 20 ALA A 456 THR A 466 1 11 HELIX 21 21 PHE A 468 GLU A 475 1 8 HELIX 22 22 ILE A 13 CYS A 495 1 469 HELIX 23 23 ASN A 496 GLY A 508 1 13 HELIX 24 24 GLU A 509 ASP A 514 5 6 HELIX 25 25 ASP A 514 VAL A 525 5 12 HELIX 26 26 ASP A 527 LYS A 554 1 28 HELIX 27 27 HIS A 571 LYS A 574 5 4 HELIX 28 28 ARG A 575 GLU A 593 1 19 HELIX 29 29 TYR A 613 ASN A 631 1 19 HELIX 30 30 ARG A 649 ILE A 657 1 9 HELIX 31 31 PRO A 658 ALA A 660 5 3 HELIX 32 32 THR A 676 ASN A 684 1 9 HELIX 33 33 ALA A 695 GLY A 704 1 10 HELIX 34 34 GLU A 705 PHE A 708 5 4 HELIX 35 35 ARG A 714 GLY A 725 1 12 HELIX 36 36 ASN A 727 ILE A 735 1 9 HELIX 37 37 ILE A 735 SER A 747 1 13 HELIX 38 38 PHE A 758 HIS A 768 1 11 HELIX 39 39 LYS A 772 LYS A 792 1 21 HELIX 40 40 ASN A 793 ALA A 806 1 14 HELIX 41 41 THR A 807 PHE A 811 5 5 HELIX 42 42 SER A 812 ILE A 824 1 13 SHEET 1 AA 3 LYS A 191 ALA A 192 0 SHEET 2 AA 3 GLN A 219 PRO A 231 -1 O ASP A 227 N LYS A 191 SHEET 3 AA 3 LEU A 198 PHE A 202 -1 O LEU A 198 N ALA A 223 SHEET 1 AB 9 LYS A 191 ALA A 192 0 SHEET 2 AB 9 GLN A 219 PRO A 231 -1 O ASP A 227 N LYS A 191 SHEET 3 AB 9 VAL A 238 LYS A 247 -1 O ASN A 239 N VAL A 230 SHEET 4 AB 9 ALA A 154 ILE A 159 1 O ALA A 154 N THR A 240 SHEET 5 AB 9 ARG A 81 LEU A 85 1 O ILE A 82 N TYR A 155 SHEET 6 AB 9 VAL A 333 ASN A 338 1 O ALA A 334 N TYR A 83 SHEET 7 AB 9 CYS A 372 THR A 375 1 O ALA A 373 N LEU A 337 SHEET 8 AB 9 ALA A 451 GLY A 454 1 O ALA A 451 N TYR A 374 SHEET 9 AB 9 PHE A 479 ASN A 481 1 O GLN A 480 N GLY A 454 SHEET 1 AC 2 PHE A 89 GLY A 92 0 SHEET 2 AC 2 ALA A 129 LEU A 131 -1 O ALA A 129 N GLY A 92 SHEET 1 AD 2 ASN A 167 CYS A 171 0 SHEET 2 AD 2 TRP A 174 GLU A 178 -1 O TRP A 174 N CYS A 171 SHEET 1 AE 2 ARG A 205 HIS A 208 0 SHEET 2 AE 2 ALA A 213 VAL A 216 -1 O LYS A 214 N GLU A 207 SHEET 1 AF 3 ARG A 386 PRO A 388 0 SHEET 2 AF 3 ARG A 438 ASN A 440 -1 O ILE A 439 N TRP A 387 SHEET 3 AF 3 VAL A 431 GLU A 432 -1 O GLU A 432 N ARG A 438 SHEET 1 AG 6 LEU A 640 LEU A 645 0 SHEET 2 AG 6 ARG A 601 GLY A 606 1 O ARG A 601 N ARG A 641 SHEET 3 AG 6 LEU A 562 VAL A 567 1 O LEU A 562 N THR A 602 SHEET 4 AG 6 LEU A 662 GLN A 665 1 O LEU A 662 N VAL A 565 SHEET 5 AG 6 LEU A 687 GLY A 690 1 O LEU A 687 N SER A 663 SHEET 6 AG 6 PHE A 709 ILE A 710 1 O PHE A 709 N GLY A 690 LINK NZ LYS A 680 C4A PLP A 999 1555 1555 1.33 CRYST1 128.966 128.966 116.186 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007754 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007754 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008607 0.00000